XML 38 R8.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Cash flows from operating activities:    
Net income (loss) $ (35,592) $ 1,424
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 4,512 3,916
Impairment charge 39,835  
Deferred income taxes (1,813) 470
Non-cash interest 169 251
Amortization of syndication contracts 130 124
Payments on syndication contracts (130) (135)
Equity in net (income) loss of nonconsolidated affiliate   156
Non-cash stock-based compensation 789 800
(Gain) loss on disposal of property and equipment   86
Changes in assets and liabilities:    
(Increase) decrease in accounts receivable 7,482 13,657
(Increase) decrease in prepaid expenses and other assets 1,026 869
Increase (decrease) in accounts payable, accrued expenses and other liabilities (4,394) (7,311)
Net cash provided by operating activities 12,014 14,307
Cash flows from investing activities:    
Purchases of property and equipment (2,671) (6,072)
Purchases of intangible assets (155)  
Proceeds from marketable securities 16,617 10,721
Purchases of investments   (200)
Net cash provided by (used in) investing activities 13,791 4,449
Cash flows from financing activities:    
Tax payments related to shares withheld for share-based compensation plans   (751)
Payments on long-term debt (750) (750)
Dividends paid (4,218) (4,271)
Repurchase of Class A common stock (525) (7,706)
Net cash used in financing activities (5,493) (13,478)
Effect of exchange rates on cash, cash equivalents and restricted cash 77 (8)
Net increase (decrease) in cash, cash equivalents and restricted cash 20,389 5,270
Cash, cash equivalents and restricted cash:    
Beginning 33,857 47,465
Ending 54,246 52,735
Cash payments for:    
Interest 2,511 3,239
Income taxes 145 623
Supplemental disclosures of non-cash investing and financing activities:    
Capital expenditures financed through accounts payable, accrued expenses and other liabilities 1,770 1,460
Contingent consideration included in accounts payable, accrued expenses and other liabilities $ 1,641 $ 8,478